21,662 reports of this reaction
3.0% of all ACETAMINOPHEN 500MG reports
#1 most reported adverse reaction
OFF LABEL USE is the #1 most commonly reported adverse reaction for ACETAMINOPHEN 500MG, manufactured by Allegiant Health. There are 21,662 FDA adverse event reports linking ACETAMINOPHEN 500MG to OFF LABEL USE. This represents approximately 3.0% of all 734,137 adverse event reports for this drug.
Patients taking ACETAMINOPHEN 500MG who experience off label use should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OFF LABEL USE is a less commonly reported adverse event for ACETAMINOPHEN 500MG, but still significant enough to appear in the safety profile.
In addition to off label use, the following adverse reactions have been reported for ACETAMINOPHEN 500MG:
The following drugs have also been linked to off label use in FDA adverse event reports:
OFF LABEL USE has been reported as an adverse event in 21,662 FDA reports for ACETAMINOPHEN 500MG. This does not prove causation, but indicates an association observed in post-market surveillance data.
OFF LABEL USE accounts for approximately 3.0% of all adverse event reports for ACETAMINOPHEN 500MG, making it one of the most commonly reported side effect.
If you experience off label use while taking ACETAMINOPHEN 500MG, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.